More directors for Cello Health Insight
July 22, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Directors, Sunil Sharma, Zahidah Ahmad, cello health insight
Healthcare research agency Cello Health Insight has made two director-level appointments on the back of a wave of new hires.
Sovaldi scores in HIV patients
July 21, 2014Sales and Marketing Gilead, HIV, JAMA, hep C, hepatitis C, sovaldi
Patients with HIV and hepatitis C virus (HCV) have responded well to a combination of Gilead Sciences’ Sovaldi and ribavirin …
Social media driving doctor complaints
July 21, 2014Medical Communications, Sales and Marketing Facebook, GMC, Twitter, doctors, social media
The advent of social media sites such as Twitter and Facebook are fuelling complaints about doctors, according to a new …
IPF grabs headlines at American Thoracic Society conference
July 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IPF, ats, ats 2014, brett wells, idiopathic pulmonary fibrosis, san diego, thoracic society
Just prior to landing in San Diego it was somewhat disconcerting to see fire spreading across the terrain and huge …
AstraZeneca reveals Cambridge plans
July 21, 2014Research and Development, Sales and Marketing AstraZeneca, Cambridge, cbc, research, silicon fen
AstraZeneca’s new international HQ on the Cambridge Biomedical Campus (CBC), due to open in two years’ time, will feature an …
Depomed hires Kyalin chief executive
July 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Depomed, Srinivas Rao
California-based speciality pharma firm Depomed has appointed Dr Srinivas Rao as its chief medical officer (CMO) and senior VP. Rao …
AbbVie agrees to buy Shire for £32bn
July 18, 2014Sales and Marketing AbbVie, Abbott, Humira, Shire, merger, new abbvie, takeover
Shire has accepted a £32 billion takeover deal from AbbVie after months of rejections and uncertainty. The firm, which is …
GSK melanoma drugs beat rival in new study
July 18, 2014Sales and Marketing GSK, Roche, Tafinlar, Yervoy, Zelboraf, mekinist, melanoma
GlaxoSmithKline’s new combination melanoma treatment has bested Roche’s established oncology drug Zelboraf when treating patients with the deadliest form of …
Mixed bag for Genentech dementia drug
July 18, 2014Research and Development, Sales and Marketing Alzheimer's, Genentech, crenezumab, dementia
A Phase II clinical trial for Genentech’s investigational Alzheimer’s drug failed to meet its primary endpoints – but the company …
Pfizer to pay $360m for InnoPharma
July 18, 2014Sales and Marketing Pfizer, injectables, innopharma
Pfizer is to pay as much as $360 million for private pharma development company InnoPharma in a financial arrangement comprising …
New chairman for Leukemia & Lymphoma Society
July 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Leukemia & Lymphoma. jim davis
James Davis has been elected chairman of the national board of directors of The Leukemia & Lymphoma Society (LLS). Davis …
New drugs see J&J sales rise
July 17, 2014Medical Communications, Sales and Marketing J&J, JJ, Q2, hepatitis C, olysio, sovaldi
Johnson & Johnson saw sales rise 9.1% to $19.5 billion year on year on the back of a strong performance …
Bayer hires litigation head from Pfizer
July 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Malini Moorthy, Pfizer
Bayer Healthcare has appointed Malini Moorthy to head up its litigation department in the US. Moorthy joins the German firm from …
Lilly signs Immunocore deal
July 17, 2014Research and Development, Sales and Marketing Cancer, Oxford, biotech, immunocore, lilly
Eli Lilly has signed a deal with one of the UK’s most high-profile biotech firms to research and potentially develop …
Deallus Consulting sees new chief executive
July 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Claudio D’Ambrosio, consulting, deallus
Life sciences consultancy firm Deallus Consulting has confirmed its new chief executive is to be Dr Claudio D’Ambrosio. D’Ambrosio succeeds …
Migrants must pay more for treatment on NHS
July 16, 2014Medical Communications, Sales and Marketing NHS, health tourism, migrants
Non-EU citizens will soon have to pay 150% of the cost of treatment on the NHS under new plans announced …
FDA speedy review for new Avastin licence
July 16, 2014Research and Development, Sales and Marketing Cancer, Roche, avastin, cervical cancer
The FDA has granted priority review status for Roche’s Avastin (bevacizumab) plus chemotherapy in women with persistent, recurrent or metastatic …
Hikma completes Bedford Laboratories purchase
July 16, 2014Manufacturing and Production Ben Venue, Boehringer, Hikma, bedford laboratories
Hikma has completed its acquisition of assets of the US generic injectables business Bedford Laboratories from Ben Venue Laboratories, a …
Chiltern acquires Ockham to help lift status
July 16, 2014Manufacturing and Production CRO, chiltern, contract research, fsp, ockham
Chiltern has today acquired a full stake in fellow contract research organisation Ockham as both companies look to merge their …
Novartis makes Alzheimer’s deal
July 16, 2014Research and Development, Sales and Marketing Alzheimer's, Genentech, Novartis, bai, epstein
Novartis is to collaborate with the Banner Alzheimer’s Institute (BAI) to test two of the Swiss company’s investigational anti-amyloid treatments. …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
